Relief Therapeutics Holding AG Cash Flow Reinvestment Rate
Relief Therapeutics Holding AG cash flow reinvestment rate. Relief Therapeutics Holding AG (RLF) has a Cash Flow Reinvestment Rate of 0.04x as of December 2024, reinvesting CHF14.00K (capex CHF14.00K ) from operating cash flow of CHF359.00K. Explore debt repayment capacity of Relief Therapeutics Holding AG to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Relief Therapeutics Holding AG (2006–2006)
Cash flow reinvestment rate of Relief Therapeutics Holding AG from 2006 to 2006. Historical reinvestment intensity for Relief Therapeutics Holding AG across 1 annual periods. Explore Relief Therapeutics Holding AG (RLF) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Relief Therapeutics Holding AG Cash Flow Reinvestment Rate by Year (2006–2006)
Relief Therapeutics Holding AG cash flow reinvestment rate by year from 2006 to 2006. Year-by-year capital reinvestment analysis for Relief Therapeutics Holding AG. For the full cash flow conversion analysis, see cash efficiency ratio of Relief Therapeutics Holding AG.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2006 | 0.21x | CHF474.60K | CHF2.28 Million | CHF474.60K | — |